| Primary |
| Depression |
47.3% |
| Pain |
8.5% |
| Fibromyalgia |
7.2% |
| Anxiety |
5.7% |
| Major Depression |
5.6% |
| Hypertension |
3.8% |
| Neuralgia |
2.9% |
| Diabetic Neuropathy |
2.7% |
| Back Pain |
2.3% |
| Insomnia |
2.0% |
| Neuropathy Peripheral |
1.9% |
| Bipolar Disorder |
1.7% |
| Diabetes Mellitus |
1.7% |
| Product Used For Unknown Indication |
1.6% |
| Sleep Disorder |
1.2% |
| Migraine |
1.1% |
| Asthma |
0.8% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Generalised Anxiety Disorder |
0.7% |
| Bipolar I Disorder |
0.6% |
|
| Hepatic Enzyme Increased |
10.7% |
| Vomiting |
9.6% |
| Suicidal Ideation |
6.8% |
| Weight Increased |
6.4% |
| Tremor |
6.3% |
| Nausea |
5.5% |
| Weight Decreased |
5.1% |
| Liver Function Test Abnormal |
5.0% |
| Somnolence |
4.6% |
| Withdrawal Syndrome |
4.5% |
| Suicide Attempt |
4.2% |
| Off Label Use |
4.1% |
| Paraesthesia |
4.1% |
| Loss Of Consciousness |
3.7% |
| Vision Blurred |
3.6% |
| Death |
3.4% |
| Hospitalisation |
3.3% |
| Aspartate Aminotransferase Increased |
3.2% |
| Syncope |
3.0% |
| Drug Exposure During Pregnancy |
2.8% |
|
| Secondary |
| Depression |
32.8% |
| Product Used For Unknown Indication |
10.4% |
| Pain |
9.0% |
| Anxiety |
7.3% |
| Fibromyalgia |
6.7% |
| Drug Use For Unknown Indication |
4.5% |
| Major Depression |
3.2% |
| Bipolar Disorder |
2.9% |
| Neuralgia |
2.9% |
| Back Pain |
2.7% |
| Hypertension |
2.7% |
| Insomnia |
2.6% |
| Neuropathy Peripheral |
2.3% |
| Diabetes Mellitus |
1.8% |
| Sleep Disorder |
1.8% |
| Blood Pressure |
1.5% |
| Migraine |
1.4% |
| Osteoporosis |
1.3% |
| Diabetic Neuropathy |
1.2% |
| Rheumatoid Arthritis |
1.1% |
|
| Weight Increased |
9.8% |
| Suicidal Ideation |
8.0% |
| Weight Decreased |
7.6% |
| Vomiting |
7.5% |
| Tremor |
7.1% |
| Suicide Attempt |
6.0% |
| Nausea |
5.4% |
| Withdrawal Syndrome |
5.4% |
| Drug Ineffective |
5.3% |
| Hepatic Enzyme Increased |
4.5% |
| Vision Blurred |
4.3% |
| Somnolence |
4.3% |
| Off Label Use |
4.0% |
| Drug Hypersensitivity |
3.3% |
| Serotonin Syndrome |
3.3% |
| Loss Of Consciousness |
3.1% |
| Pain |
3.1% |
| Vertigo |
3.1% |
| Syncope |
2.5% |
| Drug Withdrawal Syndrome |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.5% |
| Depression |
12.0% |
| Pain |
9.2% |
| Drug Use For Unknown Indication |
8.7% |
| Anxiety |
4.9% |
| Hypertension |
4.7% |
| Rheumatoid Arthritis |
4.6% |
| Fibromyalgia |
4.0% |
| Multiple Sclerosis |
3.9% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Bipolar Disorder |
2.3% |
| Insomnia |
2.3% |
| Diabetes Mellitus |
2.2% |
| Sleep Disorder |
2.1% |
| Asthma |
1.7% |
| Back Pain |
1.7% |
| Smoking Cessation Therapy |
1.7% |
| Crohn's Disease |
1.7% |
| Blood Cholesterol Increased |
1.5% |
| Osteoporosis |
1.5% |
|
| Weight Increased |
12.0% |
| Vomiting |
10.1% |
| Weight Decreased |
8.1% |
| Pain |
6.5% |
| Drug Ineffective |
6.3% |
| Type 2 Diabetes Mellitus |
6.2% |
| Nausea |
5.6% |
| Wrong Technique In Drug Usage Process |
5.6% |
| Tremor |
4.3% |
| Urinary Tract Infection |
4.2% |
| Suicidal Ideation |
4.1% |
| Somnolence |
3.7% |
| Pain In Extremity |
3.6% |
| Vision Blurred |
3.3% |
| Rash |
2.9% |
| Headache |
2.9% |
| Death |
2.8% |
| Pneumonia |
2.6% |
| Pulmonary Embolism |
2.6% |
| Injection Site Pain |
2.5% |
|
| Interacting |
| Depression |
24.1% |
| Product Used For Unknown Indication |
14.8% |
| Pain |
12.0% |
| Anxiety |
6.4% |
| Fibromyalgia |
5.7% |
| Neuralgia |
4.6% |
| Bipolar Disorder |
4.1% |
| Smoking Cessation Therapy |
4.0% |
| Drug Use For Unknown Indication |
3.5% |
| Insomnia |
3.0% |
| Hypertension |
2.7% |
| Asthma |
2.2% |
| Sleep Disorder |
2.2% |
| Post-traumatic Stress Disorder |
2.0% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Back Pain |
1.7% |
| Major Depression |
1.5% |
| Neuropathy Peripheral |
1.5% |
| Coronary Artery Disease |
1.2% |
| Parkinson's Disease |
1.2% |
|
| Drug Interaction |
15.7% |
| Tremor |
13.5% |
| Serotonin Syndrome |
10.5% |
| Weight Increased |
9.6% |
| Vomiting |
6.6% |
| Somnolence |
5.7% |
| Yawning |
4.4% |
| Judgement Impaired |
3.5% |
| Nausea |
3.5% |
| Renal Failure |
3.5% |
| Transaminases Increased |
3.1% |
| Hepatic Enzyme Increased |
2.6% |
| Hyponatraemia |
2.6% |
| Pain |
2.6% |
| Syncope |
2.6% |
| Hallucination |
2.2% |
| Toxic Encephalopathy |
2.2% |
| Urinary Tract Infection |
2.2% |
| Epilepsy |
1.7% |
| Erythema |
1.7% |
|
